Development of low-cost serological immunoassay to detect antiviral antibodies to Sars-Cov-2 Spike protein

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Funding: MCTi - CNPEM, rede virus FINEP, fapesp 2019/04458-8

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Approval in human ethics committee from Instituto Dante Pazzanese de Cardiologia, Av. Dr. Dante Pazzanese 500, Sao Paulo - SP, Brazil, zipcode 04012-909, telephone +551150856040, email cep{at}dantepazzanese.org.br. protocol# CAAE: 33608020.0.0000.5462, on June 26th, 2020.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes